Literature DB >> 19092299

The management of the patient with acromegaly and headache: a still open clinical challenge.

A Giustina1, M Gola, A Colao, L De Marinis, M Losa, N Sicolo, E Ghigo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19092299     DOI： 10.1007/BF03346442

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  46 in total

1.  Intrasellar pressure and tumor volume in pituitary tumor: relation study.

Authors:  Jackson A Gondim; Osvaldo I Tella; Michele Schops
Journal:  Arq Neuropsiquiatr       Date:  2006-12       Impact factor: 1.420

2.  Consensus statement: medical management of acromegaly.

Authors:  S Melmed; F Casanueva; F Cavagnini; P Chanson; L A Frohman; R Gaillard; E Ghigo; K Ho; P Jaquet; D Kleinberg; S Lamberts; E Laws; G Lombardi; M C Sheppard; M Thorner; M L Vance; J A H Wass; A Giustina
Journal:  Eur J Endocrinol       Date:  2005-12       Impact factor: 6.664

Review 3.  Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

Authors:  A Giustina; J D Veldhuis
Journal:  Endocr Rev       Date:  1998-12       Impact factor: 19.871

4.  Incomplete analgesic effect of lanreotide in acromegaly.

Authors:  P Maffei; C Martini; N Sicolo
Journal:  Headache       Date:  1997-05       Impact factor: 5.887

5.  Transsphenoidal surgery for acromegaly--long-term results in 100 patients.

Authors:  F Grisoli; T Leclercq; P Jaquet; M Guibout; J P Winteler; J Hassoun; F Vincentelli
Journal:  Surg Neurol       Date:  1985-05

6.  The clinical characteristics of headache in patients with pituitary tumours.

Authors:  M J Levy; M S Matharu; K Meeran; M Powell; P J Goadsby
Journal:  Brain       Date:  2005-05-11       Impact factor: 13.501

7.  Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995).

Authors:  S Kapicioğlu; E Gökce; Z Kapicioğlu; E Ovali
Journal:  Cephalalgia       Date:  1997-02       Impact factor: 6.292

8.  Pituitary volume and headache: size is not everything.

Authors:  Miles J Levy; H Rolf Jäger; Michael Powell; Manjit S Matharu; Karim Meeran; Peter J Goadsby
Journal:  Arch Neurol       Date:  2004-05

Review 9.  Cushing's Syndrome.

Authors:  Rosario Pivonello; Maria Cristina De Martino; Monica De Leo; Gaetano Lombardi; Annamaria Colao
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

10.  A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients.

Authors:  A Colao; R Pivonello; L Spinelli; M Galderisi; R S Auriemma; M Galdiero; G Vitale; M De Leo; G Lombardi
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256
View more
  6 in total

1.  Biochemical and quality of life responses to octreotide-LAR in acromegaly.

Authors:  Ruth Mangupli; Paul Camperos; Susan M Webb
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

2.  Herniation of cerebellar tonsils in acromegaly: prevalence, pathogenesis and clinical impact.

Authors:  Renzo Manara; Giulia Bommarito; Silvia Rizzati; Chiara Briani; Alessandro Della Puppa; Valentina Citton; Eva Zanchetta; Fabio Zerbo; Mario Ermani; Chiara Martini; Franco Mantero; Nicola Sicolo; Pietro Maffei; Carla Scaroni
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

3.  Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.

Authors:  Sabrina Chiloiro; Gherardo Mazziotti; Antonella Giampietro; Antonio Bianchi; Stefano Frara; Marilda Mormando; Alfredo Pontecorvi; Andrea Giustina; Laura De Marinis
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 4.  Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.

Authors:  Alin Abreu; Alejandro Pinzón Tovar; Rafael Castellanos; Alex Valenzuela; Claudia Milena Gómez Giraldo; Alejandro Castellanos Pinedo; Doly Pantoja Guerrero; Carlos Alfonso Builes Barrera; Humberto Ignacio Franco; Antônio Ribeiro-Oliveira; Lucio Vilar; Raquel S Jallad; Felipe Gaia Duarte; Mônica Gadelha; Cesar Luiz Boguszewski; Julio Abucham; Luciana A Naves; Nina Rosa C Musolino; Maria Estela Justamante de Faria; Ciliana Rossato; Marcello D Bronstein
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

Review 5.  Pegvisomant in acromegaly: an update.

Authors:  A Giustina; G Arnaldi; F Bogazzi; S Cannavò; A Colao; L De Marinis; E De Menis; E Degli Uberti; F Giorgino; S Grottoli; A G Lania; P Maffei; R Pivonello; E Ghigo
Journal:  J Endocrinol Invest       Date:  2017-02-07       Impact factor: 4.256

6.  Health-related Quality of Life in Acromegaly Patients: Results from Generic and Disease-specific Questionnaires.

Authors:  Bruno de A Oliveira; Bruna Araújo; Tainá M Dos Santos; Bárbara R Ongaratti; Carolina G S Leães Rech; Nelson P Ferreira; Júlia F S Pereira-Lima; Miriam da C Oliveira
Journal:  Indian J Endocrinol Metab       Date:  2020-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.